FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to clinical and laboratory diagnostics, intensive care. Patient’s age, degree of pulmonary tissue involvement according to chest computed tomography, ROX index and thrombocyte count are determined. Original formula is used to determine the risk of fatal outcome (R). If R is more than 0.5, a high risk of lethal outcome is predicted. If R is less than 0.5, a low risk of lethal outcome is predicted.
EFFECT: method enables to predict the risk of fatal outcome using routine history data, laboratory and instrumental diagnostics values, which in turn makes it possible to examine patients with different severity of COVID-19 infection.
1 cl, 1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 |
|
RU2803002C1 |
| METHOD OF PREDICTING THE RISK OF DEVELOPING CHRONIC HEART FAILURE IN PATIENTS WHO HAVE HAD A NEW CORONAVIRUS INFECTION COVID-19 | 2023 |
|
RU2805601C1 |
| METHOD FOR PREDICTING THE RISK OF DEATH WITHIN 6 MONTHS AFTER SUFFERING A NEW CORONAVIRUS INFECTION COVID-19 | 2021 |
|
RU2766302C1 |
| METHOD FOR PREDICTING PROBABILITY OF DEATH IN PATIENTS WITH COVID-19 HOSPITALIZED ON BASIS OF LABORATORY AND INSTRUMENTAL STUDIES | 2023 |
|
RU2806726C1 |
| METHOD OF ASSESSING THE RISK OF DEATH IN PATIENTS WITH A NEW CORONAVIRUS INFECTION | 2023 |
|
RU2802422C1 |
| METHOD FOR RAPID PREDICTION OF THE RISK OF FATAL OUTCOME IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN COMBINATION WITH THE NOVEL CORONAVIRUS INFECTION | 2021 |
|
RU2783058C1 |
| METHOD FOR PREDICTING THE LETHAL OUTCOME IN PATIENTS WITH SEVERE CoVID-19 | 2021 |
|
RU2780748C1 |
| METHOD FOR PREDICTING OUTCOMES OF PNEUMONIA IN COVID-19 | 2022 |
|
RU2795095C1 |
| METHOD FOR DETERMINING THE DEGREE OF RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN COVID-19 | 2021 |
|
RU2768575C1 |
| METHOD FOR ASSESSING THE RISK OF DEVELOPING A SEVERE COURSE OF CoVID-19 | 2022 |
|
RU2782796C1 |
